Cita APA (7a ed.)

Choby, J. E., Ozturk, T., Satola, S. W., Jacob, J. T., & Weiss, D. S. (2021). Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results? Elsevier.

Cita Chicago Style (17a ed.)

Choby, Jacob E., Tugba Ozturk, Sarah W. Satola, Jesse T. Jacob, y David S. Weiss. Does Cefiderocol Heteroresistance Explain the Discrepancy Between the APEKS-NP and CREDIBLE-CR Clinical Trial Results? Elsevier, 2021.

Cita MLA (8a ed.)

Choby, Jacob E., et al. Does Cefiderocol Heteroresistance Explain the Discrepancy Between the APEKS-NP and CREDIBLE-CR Clinical Trial Results? Elsevier, 2021.